Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-55.05	31.41	69.88
Graham Fair Price	42.23	8.53	6.00
PEG	-68.65	0.17	-0.56
Price/Book	-4.86	2.00	2.10
Price/Cash Flow	-39.97	20.91	34.83
Prices/Earnings	-52.43	17.45	36.69
Price/Sales	-52.43	2.58	5.42
Price/FCF	-39.97	20.91	34.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-45.33	0.12	0.23
Operating Margin	-6.74	0.08	0.08
ROA	100.00	0.01	< 0.005
ROE	0.01	0.03	100.00
ROIC	0.02	0.03	85.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.02	-0.06	-74.02
Dividends QOQ	-0.59	< 0.005	-99.04
EBIT QOQ	-0.62	0.87	39.91
EPS QOQ	-0.66	1.00	51.72
FCF QOQ	-0.04	0.58	1492.45
Revenue QOQ	-0.53	1.00	88.53
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	65.15	28.75	-55.87
Days Sales Outstanding (DSO)	39.82	24.43	-38.66
Inventory Turnover	1.38	3.13	126.59
Debt/Capitalization	0.40	0.41	0.89
Quick Ratio	0.99	1.10	10.86
Naive Interpretation	member

04 - Leverage & Liquidity · Positive

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	10.56	10.62	0.57
Cash	1.98	1.99	0.58
Capex	-0.02	-0.04	-101.15
Free Cash Flow	0.64	1.02	59.40
Revenue	4.10	8.25	101.15
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.70	1.70	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.17	6.26	-52.43
Naive Interpretation	Member

06 - Financial Health · Weak

Rating